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Covalent Binding of Reactive Estrogen
Metabolites to Microtubular Protein As a
Possible Mechanism of Aneuploidy
Induction and Neoplastic Cell
Transformation
by Bernd Epe,* Ulrich Harttig,* Helga Stopper,* and
Manfred MetzIert
Neoplastic celltransformation induced byestrogens andsomeothercarcinogenssuchasbenzeneappears
to involve the induction ofmitotic aneuploidy ratherthan DNAdamage and point mutations. As metabolic
activation may also play an important role in the mechanism of carcinogenesis of these nongenotoxic
compounds, we have studied the interaction of reactive quinone metabolites of various estrogens and of
benzene with the major microtubular protein, tubulin, in a cell-free system. Covalent binding of the
radioactively labeled metabolites to the a- and 3-subunit oftubulin was found to depend on the structure
of the metabolite. When the adducted tubulins were tested in vitro for their ability to polymerize to
microtubules, inhibition ofmicrotubule assembly was observed in every case, although tovarying extents.
It is proposed that the formation ofcovalent tubulin adducts may impair the formation ofmitotic spindles
and thus contribute to chromosomal nondisjunction and aneuploidy induction.
Introduction
Itiswellestablished thatcertainestrogens caninduce
cancer in experimental animals and are associated with
tumor formation in man (1). However, the mechanisms
underlying estrogen-mediated tumorigenesis are far
fromclear. Thereis ageneral consensusthathormonally
active compounds may act as promoters of cancer, in
particular in cells responding to the hormones by
growth. It is, however, still a matterofdebate whether
estrogens have the ability to induce cancerindependent
of their hormonal activity.
A suitable experimental system for studyingthe non-
hormonal mechanism ofestrogen carcinogenesis makes
use ofSyrian hamster embryo (SHE) fibroblasts. These
cells are devoid of detectable levels of estrogen recep-
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tors, and their growth is not influenced by estrogens
(2); nevertheless, they are neoplastically transforned
by a variety of natural and synthetic estrogens (2,3).
Most interestingly, transformation has been shown to
occur in the absence of detectable point mutations (3-
5). Instead, the induction of near-diploid aneuploidy
(3,5) and ofmicronuclei (6) was observed in these cells,
and a chromosomal mechanism has been proposed for
cell transformation by estrogens (5). The transforming
capability of a number of estrogens did not correlate
with their hormonal potency but rather with structural
features, suggesting that metabolic pathways may be
ofimportanceforcelltransformation. Inparticular, per-
oxidase-mediated oxidation appears to be crucial in the
metabolic activation of estrogens (2).
Inorderto elucidatetherole ofperoxidative estrogen
metabolites inthe biochemicalmechanism ofaneuploidy
induction, we have studied thecovalentbindingofthese
metabolites to microtubular proteins in vitro, as well
as thefunctional consequences ofsuch adduct formation
for microtubule assembly. Hydroquinone, a major me-
tabolite ofthe human carcinogenbenzene, was included
inthesestudiesbecauseitalsohastheabilitytoundergo
peroxidative metabolism.EPE ET AL.
Methods
Covalent Tubulin Binding
14C-Diethylstilbestrol ('4C-DES) or 14C-hydroqui-
none (33 ,uM in 1 mM phosphate buffer, pH 7.5) was
incubated with horseradish peroxidase (HRP; 1.9 U/
mL) and H202 (825 ,uM) for 10 min at 25°C. The oxi-
dation was stopped by addition of catalase (final con-
centration, 315 U/mL).
Aliquots ofthe incubation mixture containingquinoid
metabolites thus generated or of a solution of 4C-N-
ethylmaleimide (NEM) in phosphate buffer were added
to twice-cycled bovine microtubule protein (3 ,uM) (7)
inreassembly buffer [100mM2-(N-morpholino)-ethane-
sulfonic acid, 1 mM ethyleneglycol-bis-(3-aminoethyl-
ether)-N,N,N',N'-tetraacetic acid, 0.5 mM MgC92, pH
6.4] and incubated for 30 min at 37°C. Microtubule as-
sembly was initiated by addition of guanosine triphos-
phate (GTP; final concentration 0.5 mM) and allowed to
proceed for another 30 min. Protein was precipitated
by addition oftrichloroacetic acid and applied to sodium
dodecyl sulfate (SDS, 7.5%, polyacrylamide gels for
electrophoresis. After Coomassie blue staining, the
dried gels were analyzed by autoradiography and by
combustion ofexcised gel slices in aPackard 306 sample
oxidizer, followed by liquid scintillation counting.
Microtubule Assembly
Tubulin was incubated with quinoid metabolites or
unmetabolized compounds as described above. GTPwas
added, and the increase in turbidity at 350 nm was de-
terminedafter30min. Valuesobtainedfromincubations
in which the test compounds were omitted served as
reference (100% assembly). Aggregation oftubulin was
assumed ifthe increase inturbidity wasnot atleast 80%
reversible on incubation for 30 min at 4°C or ifelectron
microscopy revealed precipitated material other than
microtubules.
Results
Covalent Tubulin Binding
The peroxidative metabolism of stilbene-type estro-
gens, e.g., diethylstilbestrol and indenestrol A, pro-
ceeds via semiquinoid and quinoid intermediates (Fig.
1). Similarly, catechol metabolites of steroidal estro-
gens, e.g., 2-hydroxy-estradiol, and the benzene me-
tabolite hydroquinone yield semiquinones and quinones
upon oxidation (Fig. 1). Althoughthereactivity ofthese
products with DNAinvitro isratherlow, they can very
efficiently bind to proteins in a covalent manner (8,9).
In the absence of semiquinone (phenoxy) radicals (i.e.,
ifthe oxidation ofthe estrogens is stopped prior to the
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FIGURE 1. Peroxidative metabolism of DES, indenestrol A, 2-hydroxyestradiol, and hydroquinone.
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FIGURE 2. Covalent binding of quinoid metabolites and NEM to the a-subunit (0) and ,3-subunit (a) of tubulin. Tubulin (1.5 nmole) was
incubated in 500 ,L reassembly buffer with '4C-NEM or quinoid metabolites of "C-DES or "4C-hydroquinone under the same conditions
as used in the tests for microtubule assembly (Fig. 3). Radioactivity bound to the two subunits of the protein was determined after
polyacrylamide gel electrophoresis by combustion of excised gel slices.
addition of the protein) the binding species are most
probably quinones. Forthe quinone metabolites ofboth
stilbene-type and steroidal estrogens, aratherselective
binding reaction to the major microtubular protein,
tubulin, has been observed, which most likely involves
the C-terminal domain (10).
In Figure 2, the extent ofcovalent tubulin binding of
peroxidative metabolites of14C-DES, generatedinvitro
by reaction with HRP/H202, is compared with that of
the corresponding oxidation products of '4C-hydroqui-
none, p-benzoquinone. The binding of NEM, a nonspe-
cific sulfhydryl-reactive compound, was studied in par-
allel.
The data indicate that both NEM and oxidized hy-
droquinone bind totubulin to amuchhigherextentthan
dothe metabolites ofDES. This difference is mostprob-
ably due to the rapid rearrangement of DES to Z,Z-
dienestrol (Fig. 1) and does notreflectalowerreactivity
of DES-quinone compared to the other quinones. The
ratio of labeling of the two subunits of tubulin differs
for the different compounds tested. While metabolites
of DES and also ofother estrogens such as 2-hydroxy-
estradiol (10) bind preferentially to 1-tubulin, p-ben-
zoquinone causes a higher labeling of the a-subunit.
NEM binds to both subunits to about the same extent.
Microtubule Assembly
The relevance of the covalent binding to tubulin for
itsfunctionalactivitywasstudiedbyanalyzingthe GTP-
dependent microtubule assembly in vitro. In addition
to the compounds tested for covalent binding, indenes-
trol A was included in the assay as another stilbene-
type estrogen capable of forming quinoid metabolites
(Fig. 1). The inhibition ofmicrotubule assembly by col-
chicine served as areference. Foreach ofthe estrogens
andhydroquinone, theeffectsofthequinoidmetabolites
(allowed to bind covalently under the conditions de-
scribed)werecomparedwiththoseoftheunmetabolized
parent compounds.
The results shown in Figure 3 indicate that the me-
tabolites ofDES, hydroquinone, and indenestrol Agive
rise to a dose-dependent inhibition of microtubule as-
sembly. The effect is most probably a consequence of
the covalent binding, as it is not observed when the
reactive quinones are scavenged from the incubation
mixture withglutathione priortothe additionoftubulin
(data not shown). High concentrations of metabolites
give rise to an irreversible aggregation of tubulin as
indicated by its failure to depolymerize at 4°C and by
electron microscopy. A similar effect is observed with
NEM (Fig. 3). Unmetabolized hydroquinone and in-
denestrol A do not affect microtubule assembly in the
concentration range tested, while DES inhibits signif-
icantly (Fig. 3). As DES undergoes considerable autox-
idation under the incubation conditions used (data not
shown), itcannotbeexcludedthattheinhibitionbyDES
is, at least in part, due to the autoxidation products
rather than to the parent compound.
In Table 1, the degree of covalent binding observed
at 30% inhibition of microtubule assembly is compared
forNEMandthemetabolites ofDESandhydroquinone.
Assuming that the covalent binding is directly respon-
sible for the inhibition, we conclude from the data that
the tubulin binding of NEM is much less effective than
thatofthe quinoidmetabolites, especiallythoseofDES.
Discussion
The results presented here demonstrate that quinoid
metabolites ofestrogens can react with tubulin and dis-
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FIGURE 3. Inhibition of microtubule assembly. Tubulin, 1.5 nmole in 500 ,L reassembly buffer, was incubated with either unmetabolized
compounds (0, F, A) or products of peroxidative metabolism (X) for 30 min at 37°C. Microtubule assembly was started by adding GTP,
and the increase in turbidity was determined after 30 min. Control incubations containing all components except the test compounds were
used as reference (100% assembly). Electron microscopy and depolymerization at 4°C were used to confirm microtubule formation and
detect aggregation. Data are means of three independent experiments ± SD.
turb its GTP-dependent assembly into microtubules.
The extent of covalent binding associated with a sig-
nificant inhibition of microtubule assembly is much
lowerthanthat observed after anonspecificmodification
of sulfhydryl groups by NEM.
These findings and the observation reported here and
earlier that DES has an inhibitory effect on tubulin
assembly even without covalent binding (11,12), might
best be explained by postulating a binding site in a
functionally important domain oftubulin that has affin-
ity for estrogens and can be irreversibly blocked by the
structurally related quinoid metabolites. If a significant
covalent modification oftubulinby estrogen metabolites
takes place in vivo, it may represent the primary lesion
for the induction of neoplastic cell transformation by
these compounds, giving rise to chromosomal nondis-
junction and aneuploidy (Fig. 4).
The similar although apparently less specific inhibi-
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Table 1. Covalent binding to tubulin observed at 30% inhibition
of microtubule assembly.'
pmole covalent binding/
1.5 nmole of
Compound a-Tubulin 1-Tubulin
Quinoid metabolites of
DES 42 ± 5 63 ± 6
Hydroquinone 185 ± 55 135 ± 35
NEM 490 ± 50 400 ± 50
'Values are calculated from the data shown in Figures 2 and 3.
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FIGURE 4. Possible mechanism of cell-transformation initiated by
an interaction with the cytoskeletal protein tubulin that gives rise
to mutations on the chromosomal level.
tion of microtubule assembly by peroxidative metab-
olites of hydroquinone and, thereby, secondary me-
tabolites of benzene, suggests that the proposed
mechanism may be ofmore general importance for the
initiation ofcarcinogenesis. The carcinogenicity ofben-
zene, like that of DES, is also apparently not induced
by point mutations (13).
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